The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: A systematic review

Surgery (United States)

Volumn 151, Issue 6, 2012, Pages 860-870

  Quan, Douglas ^a   Gallinger, Steven ^b   Nhan, Cindy ^c   Auer, Rebecca A ^d   Biagi, James J ^e   Fletcher, Glenn G ^f   Law, Calvin H L ^g   Moulton, Carol Anne E ^b   Ruo, Leyo ^h   Wei, Alice C ^b   McLeod, Robin S ^g  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c CANCER CARE ONTARIO   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e QUEEN S UNIVERSITY   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

CANCER CHEMOTHERAPY; CANCER SURVIVAL; COLORECTAL CANCER; FATTY LIVER; HUMAN; LIVER INJURY; LIVER METASTASIS; LIVER RESECTION; LIVER VENOOCCLUSIVE DISEASE; LUNG METASTASIS; LUNG RESECTION; LYMPH NODE METASTASIS; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

EID: 84861645912     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2011.12.018     Document Type: Article

References (99)

1. S. Manfredi, C. Lepage, and C. Hatem Epidemiology and management of liver metastases from colorectal cancer Ann Surg 244 2006 254 259
2. G.A. Kune, S. Kune, and B. Field Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study Dis Colon Rectum 1990 938 946
3. F. Bozetti, P. Bignami, and P. Morabito Patterns of failure following surgical resection of colorectal cancer liver metastases Ann Surg 205 1987 264 270
4. H. Ekberg, K.G. Tranberg, and R. Andersson Pattern of recurrence in liver resection for colorectal secondaries World J Surg 11 1987 541 547
5. E.V. Van Cutsem, C.H. Köhne, and E. Hitre Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer N Engl J Med 360 2009 1408 1417
6. J. Scheele, A. Altendorf-Hofmann, and R. Stangl Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history Br J Surg 77 1990 1241 1246
7. R. Stangl, A. Altendorf-Hofmann, R.M. Charnley, and J. Scheele Factors influencing the natural history of colorectal liver metastases Lancet 343 1994 1405 1410
8. B. Nordlinger, M. Guiguet, and J.C. Vaillant Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients Cancer 77 1996 1254 1262
9. M.A. Choti, J.V. Sitzmann, and M.F. Tiburi Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 235 2002 759 766
10. E.K. Abdalla, J.N. Vauthey, and L.M. Ellis Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases Ann Surg 239 2004 818 825
11. S. Jonas, A. Thelen, and C. Benckert Extended resections of liver metastases from colorectal cancer World J Surg 31 2007 511 521
12. S.A. Shah, R. Bromberg, and A. Coates Survival after liver resection for metastatic colorectal carcinoma in a large population J Am Coll Surg 205 2007 676 683
13. H. Ekberg, K.G. Tranberg, and R. Andersson Major liver resection: perioperative course and management Surgery 100 1986 1 8
14. G. Steele Jr., and T.S. Ravikumar Resection of hepatic metastases from colorectal cancer. Biologic perspective Ann Surg 210 1989 127 138
15. D. Elias, D. Goere, and V. Boige Outcome of posthepatectomy-missing colorectal liver metastases after complete response to chemotherapy: impact of adjuvant intra-arterial hepatic oxaliplatin Ann Surg Oncol 14 2007 3188 3194
16. E.K. Abdalla, R. Adam, and A.J. Bilchik Improving resectability of hepatic colorectal metastases: expert consensus statement Ann Surg Oncol 13 2006 1271 1280
17. D. Sargent, and A. Grothey Adjuvant therapy for colon cancer: learning from the past to inform the future Ann Surg Oncol 17 2010 959 966
18. S. Murata, Y. Moriya, and T. Akasu Resection of both hepatic and pulmonary metastases in patients with colorectal carcinoma Cancer 83 1998 1086 1093
19. J.F. Regnard, D. Grunenwald, and L. Spaggiari Surgical treatment of hepatic and pulmonary metastases from colorectal cancers Ann Thorac Surg 66 1998 214 218
20. K. Kobayashi, M. Kawamura, and T. Ishihara Surgical treatment for both pulmonary and hepatic metastases from colorectal cancer J Thorac Cardiovasc Surg 118 1999 1090 1096
21. B.J. Robinson, T.W. Rice, and S.A. Strong Is resection of pulmonary and hepatic metastases warranted in patients with colorectal cancer? J Thorac Cardiovasc Surg 117 1999 66 75
22. J.R. Headrick, D.L. Miller, and D.M. Nagorney Surgical treatment of hepatic and pulmonary metastases from colon cancer Ann Thorac Surg 71 2001 975 979
23. H. Ike, H. Shimada, and S. Togo Sequential resection of lung metastasis following partial hepatectomy for colorectal cancer Br J Surg 89 2002 1164 1168
24. S. Nagakura, Y. Shirai, and Y. Yamato Simultaneous detection of colorectal carcinoma liver and lung metastases does not warrant resection J Am Coll Surg 193 2003 153 160
25. D. Elias, J.F. Ouellet, and N. Bellon Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases Br J Surg 90 2003 567 574
26. T.C. Mineo, V. Ambrogi, and G. Tonini Long-term results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma J Am Coll Surg 197 2003 386 391
27. R.H. Reddy, B. Kumar, and R. Shah Staged pulmonary and hepatic metastasectomy in colorectal cancer - is it worth it? Eur J Cardiothorac Surg 25 2004 151 154
28. S.A. Shah, R. Haddad, and W. Al Sukhni Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma J Am Coll Surg 203 2006 468 475
29. S. Takahashi, K. Nagai, and N. Saito Multiple resections for hepatic and pulmonary metastases of colorectal carcinoma Jpn J Clin Oncol 37 2007 186 192
30. G. Miller, P. Biernacki, and N.E. Kemeny Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases J Am Coll Surg 205 2007 231 238
31. H. Neeff, W. Horth, and F. Makowiec Outcome after resection of hepatic and pulmonary metastases of colorectal cancer J Gastrointest Surg 13 2009 1813 1820
32. K. Yasui, T. Hirai, and T. Kato A new macroscopic classification predicts prognosis for patient with liver metastases from colorectal cancer Ann Surg 226 1997 582 586
33. M. Minagawa, M. Makuuchi, and G. Torzilli Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results Ann Surg 231 2000 487 499
34. R.L. Jamison, J.H. Donohue, and D.M. Nagorney Hepatic resection for metastatic colorectal cancer results in cure for some patients Arch Surg 132 1997 505 510
35. S. Iwatsuki, I. Dvorchik, and J.R. Madariaga Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system J Am Coll Surg 183 1999 291 299
36. M. Rees, P.P. Tekkis, F.K. Welsh, T. O'Rourke, and T.G. John Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients Ann Surg 247 2008 125 135
37. J.J. Bennett, C.R. Schmidt, and D.S. Klimstra Perihepatic lymph node micrometastases impact outcome after partial hepatectomy for colorectal metastases Ann Surg Oncol 15 2008 1130 1136
38. K.T. Beckurts, A.H. Holscher, and S. Thorban Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases Br J Surg 84 1997 1081 1084
39. N. Kokudo, T. Sato, and M. Seki Hepatic lymph node involvement in resected cases of liver metastases from colorectal cancer Dis Colon Rectum 41 1999 1285 1290
40. S. Nakamura, S. Suzuki, and H. Konno Resection of hepatic metastases of colorectal carcinoma: 20 years' experience J Hepatobiliary Pancreat Surg 6 1999 16 22
41. D. Jaeck, H. Nakano, and P. Bachellier Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study Ann Surg Oncol 9 2002 430 438
42. C. Laurent, A. Sa Cunha, and E. Rullier Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis J Am Coll Surg 198 2004 884 891
43. R. Adam, R.J. de Haas, and D.A. Wicherts Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol 26 2008 3672 3680
44. T. Aoki, N. Umekita, and S. Tanaka Prognostic value of concomitant resection of extrahepatic disease in patients with liver metastases of colorectal origin Surgery 143 2008 706 714
45. D.R. Carpizo, C. Are, and W. Jarnagin Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center Ann Surg Oncol 16 2009 2138 2146
46. E. Oussoultzoglou, B. Romain, and F. Panaro Long-term survival after liver resection for colorectal liver metastases in patients with hepatic pedicle lymph nodes involvement in the era of new chemotherapy regimens Ann Surg 249 2009 879 886
47. B. Ohlsson, U. Stenram, and K.G. Tranberg Resection of colorectal liver metastases: 25-year experience World J Surg 22 1998 268 276
48. R.J. de Haas, A.C. Rahy Martin, and D.A. Wicherts Long-term outcome in patients with adrenal metastases following resection of colorectal liver metastases Br J Surg 96 2009 935 940
49. Y. Fong, J. Fortner, and R.L. Sun Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 1999 309 318
50. T. Kato, K. Yasui, and T. Hirai Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions Dis Colon Rectum 46 2003 S22 S31
51. K. Tanaka, H. Shimada, and M. Ueda Role of hepatectomy in treating multiple bilobar colorectal cancer metastases Surgery 143 2008 259 270
52. J. Figueras, F. Burdio, and E. Ramos Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections Ann Oncol 18 2007 1190 1195
53. J. Figueras, J. Torras, and C. Valls Surgical resection of colorectal liver metastases in patients with expanded indications: a single-center experience with 501 patients Dis Colon Rectum 50 2007 478 488
54. N. Kokudo, M. Seki, and H. Ohta Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases Ann Surg Oncol 5 1998 706 712
55. J. Figueras, C. Valls, and A. Rafecas Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases Br J Surg 88 2001 980 985
56. P.J. Allen, N. Kemeny, and W. Jarnagin Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases J Gastrointest Surg 7 2003 109 115
57. K. Tanaka, R. Adam, and H. Shimada Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver Br J Surg 90 2003 963 969
58. R. Adam, G. Pascal, and D. Castaing Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 240 2004 1052 1061
59. S. Yedibela, L. Elad, and A. Wein Neoadjuvant chemotherapy does not increase postoperative complication rate after resection of colorectal liver metastases Eur J Surg Oncol 31 2005 141 146
60. A. Zaniboni, V. Torri, and A. Tinazzi Neoadjuvant oxaliplatin-based chemotherapy for liver metastases from colorectal cancer. An Italian survey Tumori 91 2005 383 387
61. M. Karoui, C. Penna, and M. Min-Hashem Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases Ann Surg 243 2006 1 7
62. J.N. Vauthey, T.M. Pawlik, and D. Ribero Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases [see comment] J Clin Oncol 24 2006 2065 2072
63. M.M. Aloysius, A.M. Zaitoun, and I.J. Beckingham The pathological response to neoadjuvant chemotherapy with FOLFOX-4 for colorectal liver metastases: a comparative study Virchows Arch 451 2007 943 948
64. J.C. Hewes, S. Dighe, and R.W. Morris Preoperative chemotherapy and the outcome of liver resection for colorectal metastases World J Surg 31 2007 353 364
65. S.B. Kesmodel, L.M. Ellis, and E. Lin Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases J Clin Oncol 26 2008 5254 5260
66. H.Z. Malik, S. Farid, and A. Al-Mukthar A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: a case-controlled study Ann Surg Oncol 14 2007 3519 3526
67. R. Parks, M. Gonen, and N. Kemeny Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents J Am Coll Surg 204 2007 753 761
68. T.M. Pawlik, K. Olino, and A.L. Gleisner Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome J Gastrointest Surg 11 2007 860 868
69. A. Sahajpal, C.M. Vollmer Jr., and E. Dixon Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes J Surg Oncol 95 2007 22 27
70. F.K. Welsh, H.S. Tilney, and P.P. Tekkis Safe liver resection following chemotherapy for colorectal metastases is a matter of timing Br J Cancer 96 2007 1037 1042
71. D.G. Blazer III, Y. Kishi, and D.M. Maru Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases J Clin Oncol 26 2008 5344 5351
72. B. Gruenberger, D. Tamandl, and J. Schueller Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer J Clin Oncol 26 2008 1830 1835
73. B. Gruenberger, W. Scheithauer, and R. Punzengruber Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases BMC Cancer 8 2008 120
74. M.N. Mehta, R. Ravikumar, and C.A. Coldham Effect of preoperative chemotherapy on liver resection for colorectal liver metastases Eur J Surg Oncol 34 2008 782 786
75. E. Mitry, A.L. Fields, and H. Bleiberg Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials J Clin Oncol 26 2008 4906 4911
76. H. Nakano, E. Oussoultzoglou, and E. Rosso Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy Ann Surg 247 2008 118 124
77. B. Nordlinger, H. Sorbye, and B. Glimelius Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 2008 1007 1016
78. S.K. Reddy, M.A. Morse, and H.I. Hurwitz Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases J Am Coll Surg 206 2008 96 106
79. A. Brouquet, S. Benoist, and C. Julie Risk factors for chemotherapy-associated liver injuries: a multivariate analysis of a group of 146 patients with colorectal metastases Surgery 145 2009 362 371
80. N.D. Karanjia, J.T. Lordan, and W.J. Fawcett Survival and recurrence after neo-adjuvant chemotherapy and liver resection for colorectal metastases: a ten year study Eur J Surg Oncol 35 2009 838 843
81. N. Lubezky, R. Geva, and E. Shmueli Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases? World J Surg 33 2009 1028 1034
82. U.P. Neumann, A. Thelen, and C. Rocken Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases Surgery 146 2009 52 59
83. C.R. Scoggins, M.L. Campbell, and C.S. Landry Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases Ann Surg Oncol 16 2009 35 41
84. G. Portier, D. Elias, and O. Bouche Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial J Clin Oncol 24 2006 4976 4982
85. B. Langer, H. Blieberg, and R. Labianca Fluorouracil (FU) plus l-leucovorin (l-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer (CRC): results of the ENG (EORTC/NCIC CTG/GIVIO) randomized trial Proc Am Soc Clin Oncol 21 2002 abstr 592
86. M. Rivoire, F. De Cian, and P. Meeus Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma Cancer 95 2002 2283 2292
87. G. Nuzzo, F. Giuliante, and F. Ardito Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy J Gastrointest Surg 11 2007 318 324
88. E. Skof, M. Rebersek, Z. Hlebanja, and J. Ocvirk Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial BMC Cancer 9 2009 120
89. A. Wein, C. Riedel, and F. Kockerling Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid Ann Oncol 12 2001 1721 1727
90. A. Abad, B. Massuti, and A. Anton Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II study Acta Oncol 47 2008 286 292
91. G. Masi, F. Loupakis, and L. Pollina Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases Ann Surg 249 2009 420 425
92. R. Adam, V. Delvart, and G. Pascal Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg 240 2004 644 657
93. L. Capussotti, A. Muratore, and M.M. Mulas Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases Br J Surg 93 2006 1001 1006
94. R. Adam, T. Aloia, and F. Levi Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy J Clin Oncol 25 2007 4593 4602
95. R. Adam, D.A. Wicherts, and R.J. de Haas Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol 27 2009 1829 1835
96. S. Benoist, A. Brouquet, and C. Penna Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24 2006 3939 3945
97. G. Fiorentini, A. Del Conte, and M. De Simone Complete response of colorectal liver metastases after intra-arterial chemotherapy Tumori 94 2008 489 492
98. K. Tanaka, H. Takakura, K. Takeda, K. Matsuo, Y. Nagano, and I. Endo Importance of complete pathologic response to prehepatectomy chemotherapy in treating colorectal cancer metastases Ann Surg 250 2009 935 942
99. D. Elias, O. Youssef, and L. Sideris Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy J Surg Oncol 86 2004 4 9